The Global Health Body Raises Warning Over Severe Shortage of Weight-Loss Jabs
Under a tenth of individuals that would benefit from weight-loss injections including Wegovy have access to them, caution the World Health Organization as it issues its inaugural recommendations on the therapies.
Given over a billion people worldwide now obese, it is calling for broader and more equitable availability to this class of drugs.
Per forecasts, in excess of 2,000,000,000 are projected to be living with obesity by 2030 unless action is taken.
"The new guidance affirms that excess weight is a chronic disease that can be addressed with comprehensive and lifelong treatment," remarked WHO director-general Tedros Adhanom Ghebreyesus.
High costs, insufficient output, and logistical bottlenecks are major hurdles to widespread availability to the jabs that can help people shift substantial body mass, explains the agency.
Skinny Jab Shortage
Despite the current most favorable scenario, the manufacturing of these medications might only reach about 100 million people – fewer than 10% of eligible patients, per the WHO.
The advice urges countries and companies to increase access, through measures like licensing agreements.
The intellectual property rights on a key compound – the primary component of the drug Wegovy – is set to lapse in a number of countries in 2026.
How Weight-Loss Injections Work
The injections replicate a biological compound to delay gastric emptying, suppress the appetite and increase feelings of fullness so users consume fewer calories.
Patients typically begin shedding pounds after several weeks of commencing the regular doses.
Studies points to patients may see weight return a year later of discontinuing the medication, as their normal hunger return.
Being above a healthy weight elevates your likelihood for contracting medical conditions, including type 2 diabetes, cardiovascular issues, brain attack, and some malignancies.
Obesity concerns individuals in every country and was responsible for millions of fatalities worldwide in 2024, according to the WHO.
